AwardedSpainGoods€55,775
Suministro de los principios activos denominados "Mavacamten 15 MG ORAL", "Mavacamten 5 MG ORAL", "Mavacamten 10 MG ORAL","Deucravacitinib 6MG" Y "Fedratinib 100 MG".
- Published
- Published 25 June 2025
Overview
El objeto del contrato viene determinado por el suministro del suministro de los principios activos denominados "Mavacamten 15 MGORAL", "Mavacamten 5 MG ORAL", "Mavacamten 10 MG ORAL", "Deucravacitinib 6MG" Y "Fedratinib 100 MG".
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €55,775
- Procedure
- Direct
- Published
- 25 June 2025
Various medicinal products
Award outcome
- Awarded value
- €174,369
- Award date
- 1 May 2025
- BRISTOL-MYERS SQUIBB
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
25 June 2025
Contracting authority
Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
Procuring entityLas Palmas de Gran Canaria, Spain
ID_PLATAFORMA: 21050930148853
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.